Cordlife Group Company Description
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally.
It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples.
The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services.
The company also provides corneal lenticule banking, gut microbiome banking, and lifestyle genetic screening services for adults.
In addition, it offers Moms Up, a mobile application that offers parenting resources, as well as sprouts for health, wellness, and lifestyle needs.
Further, the company provides medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services.
Cordlife Group Limited was incorporated in 2001 and is based in Singapore.
| Country | Singapore |
| Founded | 2001 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 538 |
| CEO | Xiaoling Chen |
Contact Details
Address: 1 Kim Seng Promenade Singapore, 237994 Singapore | |
| Phone | 65 6238 0808 |
| Website | cordlife.com |
Stock Details
| Ticker Symbol | CLIFF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | SGD |
| ISIN Number | SG2E64980112 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| Xiaoling Chen | Group Chief Executive Officer, Executive Director and CEO of Singapore |
| Lingyun Zhai | Executive Chairman |